![Alastair Kilgour](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alastair Kilgour
Fondateur chez
Parkwalk Advisors Ltd. (Venture Capital)
Profil
Alastair Hugh Lowell Kilgour is the founder of Parkwalk Advisors Ltd. (founded in 2009) and Parkwalk Advisors Ltd. (Venture Capital) (founded in 2009) where he holds the titles of Partner and Chief Investment Officer respectively.
Currently, Mr. Kilgour holds the positions of Director & Investment Director at Congenica Ltd., Director at Albert Innovations Ltd., Director at PetMedix Ltd., and Director at Victoria Innovations Ltd. Mr. Kilgour has previously worked as a Director at First Light Fusion Ltd., PhoreMost Ltd., and Predictimmune Ltd. He also served as an Independent Non-Executive Director at Mirriad Advertising Plc from 2017 to 2023 and as a Partner at ARK Securities Ltd.
Postes actifs de Alastair Kilgour
| Sociétés | Poste | Début |
|---|---|---|
Parkwalk Advisors Ltd. (Venture Capital)
 Parkwalk Advisors Ltd. (Venture Capital) Investment ManagersFinance Parkwalk Advisors invests in companies located in the United Kingdom. The firm focuses on a cleantech, deeptech, and healthtech sectors. It participates in seed, early and later stage capital requirements. It makes follow-on investments along with co-investments. | Fondateur | 05/06/2009 |
Congenica Ltd.
 Congenica Ltd. Packaged SoftwareTechnology Services Operates as a digital health company that enables analysis of genomic data | Directeur en chef des Investissements | - |
Albert Innovations Ltd. | Directeur/Membre du Conseil | - |
PetMedix Ltd.
 PetMedix Ltd. BiotechnologyHealth Technology Develops therapeutic antibodies for chronic and terminal diseases pets | Directeur/Membre du Conseil | - |
Victoria Innovations Ltd. | Directeur/Membre du Conseil | 02/12/2016 |
Anciens postes connus de Alastair Kilgour
| Sociétés | Poste | Fin |
|---|---|---|
| MIRRIAD ADVERTISING PLC | Directeur/Membre du Conseil | 01/06/2023 |
Predictimmune Ltd.
 Predictimmune Ltd. Medical SpecialtiesHealth Technology Develops tools for guiding treatment options in immune-mediated inflammatory diseases | Directeur/Membre du Conseil | 19/07/2019 |
ARK Securities Ltd. | Corporate Officer/Principal | - |
PhoreMost Ltd.
 PhoreMost Ltd. Pharmaceuticals: MajorHealth Technology Operates as a drug discovery company | Directeur/Membre du Conseil | - |
| ░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
14
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Mirriad Advertising Plc
 Mirriad Advertising Plc Advertising/Marketing ServicesCommercial Services Provides in-video advertising technology platform solutions | Commercial Services |
Parkwalk Advisors Ltd.
 Parkwalk Advisors Ltd. Investment ManagersFinance Provides investment advisory services | Finance |
ARK Securities Ltd. | |
Parkwalk Advisors Ltd. (Venture Capital)
Parkwalk Advisors Ltd. (Venture Capital) Investment ManagersFinance Parkwalk Advisors invests in companies located in the United Kingdom. The firm focuses on a cleantech, deeptech, and healthtech sectors. It participates in seed, early and later stage capital requirements. It makes follow-on investments along with co-investments. | Finance |
First Light Fusion Ltd.
 First Light Fusion Ltd. Miscellaneous Commercial ServicesCommercial Services Manages a research intensive company in energy and process engineering | Commercial Services |
Congenica Ltd.
Congenica Ltd. Packaged SoftwareTechnology Services Operates as a digital health company that enables analysis of genomic data | Technology Services |
PhoreMost Ltd.
PhoreMost Ltd. Pharmaceuticals: MajorHealth Technology Operates as a drug discovery company | Health Technology |
Predictimmune Ltd.
Predictimmune Ltd. Medical SpecialtiesHealth Technology Develops tools for guiding treatment options in immune-mediated inflammatory diseases | Health Technology |
Albert Innovations Ltd. | |
PetMedix Ltd.
PetMedix Ltd. BiotechnologyHealth Technology Develops therapeutic antibodies for chronic and terminal diseases pets | Health Technology |
Victoria Innovations Ltd. |
Choisissez Zonebourse 
